BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 32773164)

  • 1. Hereditary diffuse CDH1 positive gastric cancer. Prophylactic gastrectomy?
    Sánchez Fuentes PA; Vidaña Márquez E; Velasco Albendea FJ
    Med Clin (Barc); 2021 Jul; 157(1):46-48. PubMed ID: 32773164
    [No Abstract]   [Full Text] [Related]  

  • 2. Controversies and strengths in prophylactic total gastrectomy for germline CDH1 pathogenic variant carriers.
    Davis JL; Strong VE
    Eur J Cancer Prev; 2023 Jul; 32(4):308-309. PubMed ID: 37038999
    [No Abstract]   [Full Text] [Related]  

  • 3. Total Gastrectomy for CDH-1 Mutation Carriers: An Institutional Experience.
    DiBrito SR; Blair AB; Prasath V; Habibi M; Harmon JW; Duncan MD
    J Surg Res; 2020 Mar; 247():438-444. PubMed ID: 31685251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Laparoscopic Prophylactic Total Gastrectomy for Hereditary Diffuse Gastric Cancer in
    Ithurralde-Argerich J; Rosner L; Rizzolo M; Faerberg A; Puma R; Ferro D; Duque C; Kujaruk M; Cuenca-Abente F
    J Laparoendosc Adv Surg Tech A; 2021 Jul; 31(7):729-737. PubMed ID: 34097461
    [No Abstract]   [Full Text] [Related]  

  • 5. Points to consider regarding prophylactic total gastrectomy in germline CDH1 variant carriers.
    Corso G; Davis JL; Strong VE
    J Surg Oncol; 2024 May; 129(6):1082-1088. PubMed ID: 38389278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Establishing a center of excellence for hereditary diffuse gastric cancer syndrome.
    Drake J; Schreiber KC; Lopez R; Fasaye GA; Connolly M; Quezado M; Heller T; Hernandez JM; Davis JL
    J Surg Oncol; 2019 May; 119(6):673-674. PubMed ID: 30618047
    [No Abstract]   [Full Text] [Related]  

  • 7. Overview on new progress of hereditary diffuse gastric cancer with
    Hu MN; Hu SH; Zhang XW; Xiong SM; Deng H
    Tumori; 2020 Oct; 106(5):346-355. PubMed ID: 32811340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of c.1531C>T Pathogenic Variant in the
    Norero E; Alarcon MA; Hakkaart C; de Mayo T; Mellado C; Garrido M; Aguayo G; Lagos M; Torres J; Calvo A; Guilford P; Corvalan AH
    Int J Mol Sci; 2019 Oct; 20(20):. PubMed ID: 31600923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Global distribution of prophylactic total gastrectomy in E-cadherin (CDH1) mutations.
    Corso G; Magnoni F; Nicastro V; Bagnardi V; Trovato CM; Veronesi P
    Semin Oncol; 2022 Apr; 49(2):130-135. PubMed ID: 35393124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Preventive resection of hereditary diffuse gastric cancer].
    Hoogerbrugge N; Ligtenberg MJ; Nagengast FM; Bonenkamp JJ; van Krieken JH
    Ned Tijdschr Geneeskd; 2006 Nov; 150(44):2417-20. PubMed ID: 17131699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prophylactic laparoscopic-assisted total gastrectomy for hereditary diffuse gastric cancer.
    Francis WP; Rodrigues DM; Perez NE; Lonardo F; Weaver D; Webber JD
    JSLS; 2007; 11(1):142-7. PubMed ID: 17651578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CDH1-related blepharocheilodontic syndrome is associated with diffuse gastric cancer risk.
    LeBlanc S; Naveen D; Haan E; Barnett C; Rawlings L; Roscioli T; Poplawski N
    Am J Med Genet A; 2020 Jul; 182(7):1780-1784. PubMed ID: 32302040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Case report: acute abdominal pain in a 37-year-old patient and the consequences for his family.
    Niemeyer E; Mofid H; Zornig C; Burandt EC; Stein A; Block A; Volk AE
    BMC Gastroenterol; 2020 May; 20(1):129. PubMed ID: 32362280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes after prophylactic gastrectomy for hereditary diffuse gastric cancer.
    van der Kaaij RT; van Kessel JP; van Dieren JM; Snaebjornsson P; Balagué O; van Coevorden F; van der Kolk LE; Sikorska K; Cats A; van Sandick JW
    Br J Surg; 2018 Jan; 105(2):e176-e182. PubMed ID: 29341148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hereditary Diffuse Gastric Cancer Syndrome and the Role of CDH1: A Review.
    Gamble LA; Heller T; Davis JL
    JAMA Surg; 2021 Apr; 156(4):387-392. PubMed ID: 33404644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes of Endoscopic Surveillance in Individuals With Genetic Predisposition to Hereditary Diffuse Gastric Cancer.
    Jacobs MF; Dust H; Koeppe E; Wong S; Mulholland M; Choi EY; Appelman H; Stoffel EM
    Gastroenterology; 2019 Jul; 157(1):87-96. PubMed ID: 30935944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is prophylactic gastrectomy indicated for healthy carriers of CDH1 gene mutations associated with hereditary diffuse gastric cancer?
    Munitiz Ruiz V; Jimeno P; Ruiz de Angulo D; Ortiz Á; Martínez de Haro LF; Marín M; Cascales P; Ruiz García G; Ortiz Ruiz E; Parrilla P
    Rev Esp Enferm Dig; 2019 Mar; 111(3):189-192. PubMed ID: 30466290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CDH1 testing: can it predict the prophylactic or therapeutic nature of total gastrectomy in hereditary diffuse gastric cancer?
    Ziogas D; Roukos DH
    Ann Surg Oncol; 2009 Oct; 16(10):2678-81. PubMed ID: 19636637
    [No Abstract]   [Full Text] [Related]  

  • 19. Pregnancy after prophylactic total gastrectomy.
    Kaurah P; Fitzgerald R; Dwerryhouse S; Huntsman DG
    Fam Cancer; 2010 Sep; 9(3):331-4. PubMed ID: 20063069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hereditary diffuse gastric cancer: translation of CDH1 germline mutations into clinical practice.
    Guilford P; Humar B; Blair V
    Gastric Cancer; 2010 Mar; 13(1):1-10. PubMed ID: 20373070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.